Litigation
May 31, 2002
Blood Test Does Not Infringe Patent, Jury Finds
SAN DIEGO - A test developed by Gen-Probe Inc. that collection centers use to screen more than 70 percent of donated blood in the United States does not infringe on a similar patent held by a company with which Gen-Probe has a licensing arrangement, a federal court jury has found.
Gen...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In